Close

Knowledge Center

Due-Diligence Is Key for Betting on Cannabis in Nevada

Nevada and cannabis

The Nevada cannabis market is unique among states with legal recreational cannabis regimes. The role of tourism plays a big role in shaping retail trends. The concentration of sales in urban centers stands apart. And the state’s regulatory framework offers benefits and challenges for cannabis companies and investors. Since July […]

Read More

Top 10 Ways People Are Consuming Cannabis in 2019

social consumption setting

How many products contain cannabis? Hundreds. Flower – of course – and pre-rolls. Vape pens and concentrates like shatter and Live Resin. Creams and massage oils. Chocolate chip cookies, coffee sodas, pills, strawberry taffy, powders for adding to hot tea or cold juice. Companies are rolling out myriad new products […]

Read More

Gummies Are as Popular as Ever

gummies cannabis

Cannabis Ingestibles cover a lot of ground, including everything from pills to slices of pie to bottles of THC-infused cold-brewed coffee. But one style of ingestible dominates the market: the gummy. During the first four months of 2019, 17 of the top 20 selling ingestible products in California, Colorado and […]

Read More

BDS Analytics’ Top 5 Insights: The Impact of Cannabis on the OTC and Prescription Drug Channels

Cannabis pharmaceutical BDS Analytics

As more U.S. states move towards legalization, cannabis consumers are taking advantage of the unique opportunity to address medical needs through the available products at their local dispensaries. Though medical cannabis is generally not covered by most U.S. insurance plans, trends indicate increased use of cannabis as an alternative to […]

Read More

Will Global Legal Cannabis Spending Exceed $40 Billion by 2024?

Consumer spending on legal cannabis worldwide reached $10.9 billion in 2018. This number is especially significant considering the variables at play: the California market transition from lightly regulated medical-only to fully regulated adult-use; the maturation of first-in, adult-use markets in Colorado and Washington; and the lackluster rollout of legal adult-use […]

Read More

The $20 Billion CBD Race

CBD Products

Whether or not you keep up with the cannabis industry, you’ve likely heard the term “CBD” recently. Seemingly overnight, CBD is appearing everywhere from beauty product lines to burger joints. As it turns out, there’s legitimate reasoning behind “today’s” latest hype. Cannabidiol, more commonly known as “CBD,” is one of […]

Read More

4/20 is Coming

4/20 BDS Analytics

The holiday always stokes robust sales. But this year’s 4/20? It’s gonna be big. We anticipate more than $100 million in sales on pot’s big day, making it the largest day of sales since dispensaries first started selling cannabis legally. The history-making sales projection revolves in part around the thousands […]

Read More

A More Conservative View of Canadian Cannabis Market Growth

Canada Legal Spending Chart

Our research on the roll-out of adult-use legalization in Canada, published today in the Cannabis Intelligence Briefing titled Canada Leads the Way on Global Cannabis Legalization, is the first research of its kind. The report models each of the 10 Canadian provinces individually. At a countrywide-level, consumer spending is now […]

Read More

Pharmaceutical Versus Dispensary Cannabinoids Competition

pharmaceuticals vs dispensaries | BDS Analytics

Epidiolex Approval Queues Up Pharmaceutical Versus Dispensary Cannabinoids Competition Pharmaceutical cannabinoids have been around since the 1980s in synthetic or semi-synthetic form for the treatment of nausea related to cancer, and anorexia related to both cancer and AIDS. The FDA approved GW Pharmaceuticals’ Epidiolex in 2018 marking the first time […]

Read More

Subscribe to Our Newsletter